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Abstract:  The  infection  of  bacterial  organisms  generally  causes  cell  death  to  facilitate  25 
microbial invasion and immune escape, both of which are involved in the pathogenesis of  26 
infectious  diseases.  In  addition  to  the  intercellular  infectious  processes,  pathogen- 27 
produced/secreted enterotoxins (mostly exotoxins) are the major weapons that kill host  28 
cells and cause diseases by inducing different types of cell death, particularly apoptosis and  29 
necrosis. Blocking these enterotoxins with synthetic drugs and vaccines is important for  30 
treating  patients  with  infectious  diseases.  Studies  of  enterotoxin-induced  apoptotic  and  31 
necrotic  mechanisms  have  helped  us  to  create  efficient  strategies  to  use  against  these   32 
well-characterized cytopathic toxins. In this article, we review the induction of the different  33 
types of cell death from various bacterial enterotoxins, such as staphylococcal enterotoxin  34 
B,  staphylococcal  alpha-toxin,  Panton-Valentine  leukocidin,  alpha-hemolysin  of  35 
Escherichia coli, Shiga toxins, cytotoxic necrotizing factor 1, heat-labile enterotoxins, and  36 
the cholera toxin, Vibrio cholerae. In addition, necrosis caused by pore-forming toxins,  37 
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apoptotic  signaling  through  cross-talk  pathways  involving  mitochondrial  damage,  1 
endoplasmic reticulum stress, and lysosomal injury is discussed.  2 
Keywords: apoptosis; necrosis; enterotoxin; exotoxin; pore-forming toxin; staphylococcal  3 
enterotoxin B; staphylococcal alpha-toxin; Panton-Valentine leukocidin; alpha-hemolysin;  4 
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  6 
1. Introduction  7 
Patients with bacteremia may develop moderate or severe sepsis or life-threatening septic shock  8 
following  multiple  organ  failure  or  multiple  organ  dysfunction  syndrome  (MOF/MODS)  [1–3].  9 
Patients with MOF/MODS have a 25–50% higher mortality rate than those without MOF/MODS [4,5].  10 
Although  a  variety  of  strategies  for  managing  sepsis  have  been  developed  [3,6],  it  is  difficult  to  11 
prevent because of its complex pathogenic mechanisms, which generally involve severe inflammation  12 
and cell death. Enterotoxinschromosomally encoded exotoxins that are originally defined by their  13 
cytopathic effectsare generally produced from pathogenic bacterial organisms, such as Escherichia coli  14 
(E.  coli)  (alpha-hemolysin  (HlyA),  Shiga  toxins  (Stxs),  cytotoxic  necrotizing  factors  1  (CNF1),   15 
heat-labile  enterotoxins  (LT))[7,8],  Staphylococcus  aureus  (S.  aureus)(staphylococcal  enterotoxins  B  16 
(SEB), staphylococcal alpha-toxins, Panton-Valentine leukocidin (PVL)[7,9], Streptococcus pneumoniae  17 
(S.  pneumoniae),  (streptolysin  and  pneumolysin)[7,10,11],  Clostridium  perfringens  (Clostridium  18 
perfringens  enterotoxins)[12],  Vibrio  cholerae  (cholera  toxins)[13],  and  Shigella  dysenteriae  19 
(Stxs)[14].  In  addition  to  inflammatory  activation,  these  enterotoxins  are  cytopathic  to  host  cells  20 
through lytic or non-lytic mechanisms by inducing necrosis or apoptosis, respectively. Apoptosis, also  21 
called programmed cell death, induced by bacterial infection is widely under investigation [15–17].  22 
Extrinsic and intrinsic pathways of apoptosis involving intracellular organelle dysfunction and caspase  23 
cascade activation are regulated for bacterial enterotoxin-induced pro-apoptotic signaling. In addition  24 
to  apoptosis,  cytopathic  studies  have  shown  that  several  enterotoxins,  including  hemolysin,  25 
staphylococcal alpha-toxin, pneumolysin, and streptolysin-O, usually cause cell death by altering the  26 
apical  membrane  permeability  of  the  targeting  cells  [7].  These  cytopathic  enterotoxins  are   27 
pore-forming  toxins  (PFTs),  also  defined  as  cytolysins.  After  these  cytolysins  bind  to  a  host  cell  28 
membrane, the mechanism for pore formation involves the insertion of a number of water-soluble  29 
single-chain polypeptides into the membrane bi-layer and the formation of hydrophilic transmembrane  30 
pores [7,18].  The generation of hydrophilic transmembrane pores, which induces necrotic lysis or  31 
permeabilization of host cells or intracellular organelles during infection, is pathogenic for disease  32 
development via the disruption of infected tissues/cells and the induction of local and/or systemic  33 
immunosuppression.  For  microbial  pathogenesis,  somatic  cell  death  and  immune  cell  death  are  34 
required for bacterial invasion and immune escape, respectively.  35 
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2. Apoptotic Cell Death  1 
Apoptosis,  also  called  programmed  cell  death,  is  generally  involved  in  bacterial  infection  and  2 
pathogenesis [15–17]. During bacterial infection, virulent factors (mostly enterotoxins) are produced  3 
and secreted from pathogens and trigger apoptotic signals. In general, cells undergo apoptosis through  4 
two major pathways, the extrinsic pathway (the death receptor pathway) or the intrinsic pathway (the  5 
mitochondrial pathway)[19–21]. In addition to enterotoxins, the invasion and endocytosis of whole  6 
pathogens  into  the  infected  cells  also  cause  apoptotic  signaling  through  extrinsic  and  intrinsic  7 
pathways [15]. It is speculated that blockage of this apoptotic signaling may confer protection against  8 
bacterial infection-induced sepsis [20,21].  9 
2.1. Extrinsic (Death Receptor-mediated) and Intrinsic (Mitochondria-Regulated) Pathways of Apoptosis  10 
Extrinsic pathways are generally initiated by the activation of death receptors through the interaction  11 
between  their  natural  ligands  or  by  inducing  death  receptor  clusterization.  Death  receptors  are  cell  12 
surface receptors that belong to the tumor necrosis factor (TNF) super family and interact with their  13 
ligands to form death receptor complexes, including Fas (CD95/Apo1)/Fas Ligand (CD95 ligand)[22],  14 
TNF  receptor  1  (p55)/TNF  and  lymphotoxin  [23],  TRAMP  (WSL-1/Apo3/DR3/LARD)/TWEAK  15 
(Apo3  ligand)[24],  TRAIL-R1  (DR4)/TRAIL  (Apo2  ligand)[25],  and  TRAIL-R2  16 
(DR5/Apo2/KILLER)/TRAIL [26]. Upon extrinsic activation, the intracellular death domain (DD) of  17 
death receptors associates with an adaptor protein called Fas-associated death domain (FADD) directly  18 
or  indirectly  via  the  TNF  receptor-associated  death  domain  [26].  The  death  receptor  associated  19 
intracellular FADD interacts with pro-caspase-8, a typical initial caspase, to form a death-inducing  20 
signaling complex required for caspase-8 activation [26]. During the process of apoptosis, there is, in  21 
general, a reduction of mitochondrial transmembrane potential followed by the release of cytochrome  22 
c, which binds to Apaf-1 and promotes caspase-9 and caspase-3 activation [27,28]. The central role of  23 
mitochondria in apoptosis is proposed to be via an intrinsic pathway. Pro-apoptotic Bax and Bid, the  24 
members of
 the Bcl-2 family with pro-apoptotic roles, translocate to the mitochondria and disrupt the  25 
membrane integrity, resulting in cytochrome c release from mitochondria to cytoplasm [29–31]. The  26 
induction of mitochondrial transmembrane permeabilization (MTP) resulted from Bax or truncated Bid  27 
(activated by caspase-8 from the extrinsic pathway) forms pores in the outer membrane directly or by  28 
interacting with the permeability of the transition pore complex [30,31]. In contrast, anti-apoptotic   29 
Bcl-2 and Bcl-xL protect these effects by maintaining the MTP through the inhibition of Bax or other  30 
pro-apoptotic factors [29]. The loss of balance of Bcl-2/Bax is believed to contribute to the progression  31 
of apoptosis.  32 
2.2. Endoplasmic Reticulum Stress-Mediated Apoptosis  33 
Stress on the endoplasmic reticulum (ER), which is the site of protein synthesis, modification, and  34 
folding, can be caused by multiple insults, such as the inhibition of glycosylation, the reduction of  35 
disulfide bonds, calcium depletion from the ER lumen, impairment of protein transport to the Golgi,  36 
and expression of mutated proteins in the ER, which can trigger an unfolded protein response (UPR)  37 
following ER stress [32–34]. These events enhance protein folding and degradation within the ER and  38 Toxins 2010, 2                                       
 
 
2161 
down-regulate protein synthesis until cells have recovered from the ER stress. However, prolonged ER  1 
stress may  eventually cause apoptosis,  and calcium homeostasis and  the UPR cannot be restored.  2 
Several apoptotic signaling pathways have been demonstrated in ER stress-induced apoptosis [32]. The  3 
ER stress-induced C/EBP homologous protein, a transcription factor that suppresses the expression of   4 
anti-apoptotic  protein  Bcl-2  and  increases  ROS  production,  is  involved  in  apoptosis  through  the  5 
mitochondrial  pathway  [33].  ER  stress-activated  c-Jun  N-terminal  kinase  is  also  involved  [34].  6 
Calpain, a calcium-dependent protease, generally causes the activation of human caspase-4, a specific  7 
ER stress-activated caspase with a 48% sequence homology to murine caspase-12 [35,36]. Notably,  8 
caspase-4 triggers apoptotic pathways, dependent or independent of caspase-9 and caspase-3 activation [32].  9 
Furthermore,  the  activation  of  caspase-2,  -3,  -7,  -8,  and  -9  have  also  been  reported  in  ER   10 
stress-induced apoptosis [37–39]. However, the role of caspase cascade activation is still controversial,  11 
owing to differences in ER stressor stimulation and cell type dependence.  12 
2.3. Lysosomal Pathway of Apoptotic Signaling  13 
The lysosome, an acidic organelle, plays a pivotal role in apoptosis and necrosis caused by various  14 
stimuli, including oxidative stress, TNF-, sphingosine, p53, and staurosporine [40,41]. However, the  15 
precise lysosomal pathway in ER stress-induced apoptosis remains unclear. Apoptotic stimuli cause  16 
lysosomal membrane permeabilization through a variety of regulatory factors, such as calcium, ROS,  17 
ceramide, sphingosine, phospholipase, Bax, Bim, Bid, and caspase [41,42]. The lysosomal proteolytic  18 
enzymes, mainly proteases of the cathepsin family, translocate to the cytosol. Once in the cytosol,  19 
cathepsin  B  and  cathepsin  D  are  the  major  mediators  triggering  apoptotic  and  necrotic  pathways,  20 
which involve Bid truncation, caspase activation, and mitochondrial damage [43]. Under apoptotic  21 
stress, both ER stress and lysosomal and mitochondrial destabilization may contribute to the initiation  22 
stage of apoptosis.  23 
3. Necrotic Cell Death  24 
Necrotic cell death is also caused by a variety of extracellular and intracellular factors, such as  25 
bacterial and viral infections, toxins, or trauma [44]. Numerous intracellular molecules are involved in  26 
necrotic cell death, including ROS, Ca
2+, calpains, cathepsins, phospholipases, and ceramide [45]. In  27 
contrast  with  apoptosis,  necrosis  is  characterized  by  severe  pathophysiological  changes,  including  28 
mitochondrial swelling, rapid loss of plasma membrane integrity, ultimate leakage of cellular contents,  29 
and  a  lack  of  typical  apoptotic  features,  such  as  internucleosomal  DNA  cleavage  and  nuclear  30 
condensation. Necrotic cell death is identified as caspase-independent cell death [46]. Exposing the  31 
release content proteins triggers acute inflammation and causes pathogenic to the host.  32 
Necrotic cell death is also induced through death receptor-mediated signaling. Activation of the  33 
death receptors, including Fas and TNF- receptors, induces a ―prototypic‖ apoptotic pathway through  34 
FADD. Under apoptosis-deficient conditions, stimulation with FasL or TNF-α still induces cell death  35 
with the morphological features of necrosis [47]. Notably, necrostatin-1, an inhibitor of RIP1, blocks  36 
Fas- and TNF- receptor-mediated necrotic cell death, namely necroptosis [48]. In addition to death  37 
receptor pathways, the signaling of pathogen recognition receptors such as the Toll-like receptor (TLR) 3  38 
[49] and TLR4 [50] and extensive DNA damage [51] can also lead to necrotic cell death.  39 Toxins 2010, 2                                       
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4. Cytotoxic Enterotoxins  1 
4.1. Cytotoxicity of S. aureus  2 
S.  aureus,  a  Gram-positive  bacterium,  causes  a  variety  of  diseases  ranging  from  minor  skin  3 
infections to life-threatening conditions such as staphylococcal septic shock [9]. Cell wall components  4 
and secreted enterotoxins have been shown to be inflammatory, cytotoxic, and septic mediators. These  5 
factors may be recognized by the innate immune system via multiple manners [52]. To date, it is  6 
believed  that  mechanisms  that  lead  to  staphylococcal  septic  shock  are  probably  multifactorial  but  7 
include immunogenic and cytotoxic injuries.  8 
Staphylococcal  superantigens,  a  large  family  of  exotoxins,  are  powerful  microbial  toxins  that  9 
activate  the  immune  system  by  binding  to  class  II  major  histocompatibility  complex  and  T-cell  10 
receptor molecules without antigen processing. There are 17 well-characterized, serologically distinct  11 
staphylococcal superantigens made by S. aureus: TSS toxin-1; staphylococcal enterotoxins (SEs) A, B,  12 
C (multiple minor variant forms exist), D, E, and I; and SE-like G, H, J, K, L, M, N, O, P, and Q [53].  13 
Superantigen SEB, a staphylococcal pyrogenic exotoxin, causes cellular cytotoxicity by inducing cell  14 
activation followed by the induction of inflammatory cytokines including TNF-, interleukin (IL)-2,  15 
IL-6, IL-10, and interferon-, and chemokines including monocyte chemoattractant protein 1 regulated  16 
on activation, and normal T-cell expressed and secreted proteins [54–58]. Further study showed that  17 
TNF- plays an initial role in inflammation on T cell-mediated toxicity in SEB-induced septic shock,  18 
whereas  anti-TNF--neutralizing  monoclonal  antibody  conferred  protection  against  SEB  [59].  19 
Interestingly, the major producer cells of TNF- are CD3 positive splenic T cells and peritoneal cells.  20 
In  addition to  the pathogenic  role of SEB  in vivo, in  vitro studies  showed that  superantigens  are  21 
enabled  to  induce  transcriptional  activation  of  the  TNF  in  T  cells  and  monocytes  [60,61].  In   22 
SEB-induced septic pathogenesis, T cells are the major cause of shock syndrome [54,59]. Furthermore,  23 
SEB may cause CD4 positive cells undergoing activation-induced cell death both in vitro and in vivo  24 
[62–65].  Izquierdo  and  colleagues  [66]  found  that  the  blockade  of  caspase  activation  inhibits   25 
SEB-induced  thymocyte  apoptosis.  Current  studies  show  that  the  induction  of  caspase-3-mediated  26 
apoptosis in SEB-exposed renal proximal tubule epithelial cells involves the signaling of Rho family  27 
proteins [67]. The molecular mechanism for SEB-induced cell apoptosis needs further investigation.  28 
The  staphylococcal  alpha-toxin,  a  water-soluble  single-chain  cytopathic  toxin  produced  by   29 
S. aureus, was the first staphylococcal exotoxin to be identified as a PFT [68]. It contains high-affinity  30 
structures  that  interact  with  a  variety  of  cells,  including  rabbit  erythrocytes,  human  platelets,  31 
monocytes and endothelial cells. After it binds onto a membrane, the generation of ring-structured  32 
hexamers is present as a pore. These pores trigger cellular responses via a Ca
2+ influx to lyse and  33 
permeabilize cell membranes. Staphylococcal alpha-toxin-exposed keratinocytes and T cells show the  34 
depletion  of  cellular  ATP  followed  by  the  degradation  of  internucleosomal  DNA  [69,70].  To  35 
characterize the type of cell death, Bantel and colleagues  [71] demonstrated that a staphylococcal  36 
alpha-toxin induces cytochrome c release in a Bcl-2-controlled manner. They further demonstrate that  37 
staphylococcal alpha-toxin causes an intrinsic mitochondrial pathway, which involves caspase-9 and  38 
caspase-3 cascade activation independently of the death receptor pathway. However, Essmann and  39 
colleagues  [72]  provided  data  suggesting  that  although  pan-caspase  inhibitor  zVAD-fmk  or  40 Toxins 2010, 2                                       
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overexpression of Bcl-2 completely decreased staphylococcal alpha-toxin-induced caspase activation  1 
and internucleosomal DNA fragmentation, they did not significantly inhibit cell death of T or breast  2 
carcinoma cells. Notably, electron microscopy demonstrated that a staphylococcal alpha-toxin induces  3 
necrotic cell death, which is characterized by cell swelling and cytoplasmic vacuolation. In addition to  4 
apoptosis  and  necrosis,  the  staphylococcal  alpha-toxin  may  facilitate  death  receptor-mediated   5 
caspase-8  activation  and  apoptosis  through  TNF-  upregulation  [73].  Taken  together,  these  data  6 
suggest that a staphylococcal alpha-toxin induces cell death in a cell type- and dose-dependent manner,  7 
including apoptosis and necrosis. Mitochondrial dysfunction caused by a staphylococcal alpha-toxin is  8 
usually  involved  either  in  apoptosis  or  necrotic  cell  death.  In  addition  to  the  involvement  of  9 
mitochondrial  injury,  Bernheimer  and  Schwartz  [74]  identified  that  bacterial  toxins,  including  the  10 
staphylococcal  alpha-toxin,  the  Clostridium  perfringens  alpha-toxin,  and  streptolysins  O  and  S,  11 
affected  lysosomes.  It  is  notable  that  lysosomotropic  agents  NH4Cl,  chloroquine,  and  monensin  12 
effectively abrogated staphylococcal alpha-toxin-induced internucleosomal DNA fragmentation [75].  13 
The involvement of lysosomal pathway in staphylococcal alpha-toxin-induced apoptosis and necrotic  14 
cell death therefore needs further investigation.  15 
Current reports demonstrate the emerging role of PVL, a key PFT, for S. aureus-induced rapidly  16 
progressive,  hemorrhagic,  necrotizing  pneumonia  [76,77].  These  pneumonias  occurred  in  younger  17 
patients, and the presence of leucopenia and the mortality rate represented 79% and 75% of cases,  18 
respectively [77]. PVL-producing S. aureus strains cause polymorphonuclear cell death by necrosis or  19 
by apoptosis [78–80]. The PVL concentration determines the type of cell death. For cell apoptosis,  20 
PVL  causes  mitochondrial  damage  followed  by  the  activation  of  caspase-9  and  caspase-3  21 
independently of pro-apoptotic Bax activation. Notably, PVL directly inserts into the outer membrane  22 
of  the  mitochondria  and  induces  the  release  of  cytochrome  c  and  Smac/DIABLO  through  pore  23 
formation [78].  24 
4.2. Cytotoxicity of E. coli  25 
Uropathogenic  E.  coli  (UPEC)  frequently  accounts  for  the  community-acquired  urinary  tract  26 
infection  (UTI),  in  both  cystitis  and  pyelonephritis.  Severe  UTI  of  type  1-piliated  UPEC  is  the  27 
common cause of bacteremia, leading to a health-threatening concern [81]. UPEC can invade epithelial  28 
cells of the urinary tract, and these bacterial inclusions can form intracellular bacterial communities to  29 
invade the host cell [82]. After the infection of type 1-piliated UPEC, exfoliation of the host bladder  30 
epithelial cells shows a rapid apoptotic mechanism involving caspase activation and internucleosomal  31 
DNA fragmentation [83]. Diffusely adhering E. coli strains expressing adhesins of the Afa/Dr family  32 
bind to epithelial cells and express a functional hemolysin that promotes cell apoptosis or necrosis [84].  33 
In  UPEC-infected  human  renal  proximal  tubular  epithelial  cells,  either  apoptosis  or  necrosis  is  34 
observed (Figure 1). This indicates that E. coli has multiple cytotoxic effects depending on the cell  35 
types of infection and the various virulent actions.  36 
Among  the  numerous  toxins  produced  by  E.  coli,  HlyA,  which  belongs  to  a  member  of  the   37 
repeats-in-toxin family of PFTs, causes cell apoptosis or necrosis [85]. HlyA possess cytotoxicity in  38 
different cells such as erythrocytes [86], granulocytes [87–90], monocytes [91], endothelial cells [92],  39 
renal tubular epithelial cells [93], and T cells [94]. The toxic effect of HlyA is due to the generation of  40 Toxins 2010, 2                                       
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the transmembrane pore after its insertion into the plasma membrane [86]. Increased permeability of  1 
cations  and  water  leads  to  cell  death.  In  human  monocyte-derived  macrophages  and  J774  cells   2 
(the murine macrophage cell line), HlyA is required to induce necrosis and apoptosis [95]. Moreover,  3 
HlyA induces neutrophil apoptosis (at lower E. coli titers) and necrosis/lysis (at lower E. coli titers) in  4 
vitro. In a rat pneumonia model, HlyA induces neutrophil necrosis/lysis rather than apoptosis [96].  5 
Figure 1. In vitro infection of Uropathogenic E. coli (UPEC) causes apoptotic and necrotic  6 
cell death in human renal proximal tubular epithelial cells. Human renal proximal tubular  7 
epithelial cells (HK-2) were infected with or without clinical isolates of UPEC (MOI = 1)  8 
for 12 h. Annexin V (green), propidium iodide (PI, red), and Hoechst 33258 (blue) were  9 
used  for  apoptotic  (solid  arrowheads),  necrotic  (empty  arrowheads),  and  nucleic  acid  10 
staining, respectively, and analyzed by confocal microscopy. Stars indicate E. coli.  11 
  12 
Besides HlyA, several serotypes of E. coli express Stxs to induce apoptosis in several cell types  13 
including  epithelial  [97–100],  endothelial  [101–104],  monocytic  [105–107],  lymphoid  [108],  and  14 
neuronal [109]. Stxs belong to the Shiga toxin family, which is made up of a group of structurally and  15 
functionally related exotoxins produced by the Shigella dysenteriae serotype 1 and enterohemorrhagic  16 
E. coli (EHEC). EHEC infection causes diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome  17 
(HUS)[110]. HUS is the most common cause of acute renal failure in children [111]. Stxs induce  18 
apoptosis and contribute to the HUS-associated injury of renal endothelium [112]. Stxs are AB chain  19 
toxins in which the B chain binds to the cell surface receptor and mediates the subsequent endocytosis  20 
of the toxin, and the A chain acts as a protein synthesis inhibitor through its RNA  N-glycosidase  21 
activity to inactivate ribosomes enzymatically [113]. The apoptotic pathways activated by Stxs are  22 
involved  in  the  initial  induction  of  ER  stress  and  the  subsequent  calcium  release  to  activate   23 
calcium-dependent cysteine protease calpain to further activate downstream caspase-8 and caspase-3.  24 
The increased expression of the death receptor 5 and TRAIL were also addressed [107]. Of note, the  25 
caspases activated by Stxs, including caspase-2, -3, -6, -8, and -9, differ depending on the different cell  26 
types  [102,105,107,114,115].  The  participation  of  Bcl-2  family  proteins  is  also  reported  in   27 
Stxs-induced apoptosis, including truncated Bid and Bax to initiate a mitochondrial pathway [97,107].  28 
The  expression  of  Mcl-1  is  down-regulated  upon  stimulation  of  Stxs  [101],  and  Bcl-2  confers  29 
protection  against  Stxs  [97,106,116].  In  addition,  the  intracellular  trafficking  of  Stxs  has  been  30 
extensively studied because the A chain of Stxs has to enter the cytoplasm to execute its cytotoxicity  31 
by inhibiting protein synthesis. After internalization, Stxs escape from the endosome and undergo  32 
retrograde delivery to the Golgi apparatus, then to the ER membranes, and finally to the cytosol, by  33 
using ER-associated degradation machinery [117,118]. Inhibiting the transportation of Stxs from the  34 Toxins 2010, 2                                       
 
 
2165 
endosome to the Golgi apparatus has been implicated to prevent Stxs-induced apoptosis [115,119]. An  1 
old theory of using protein toxins to induce apoptosis in cancer cells is still applied in some pioneering  2 
studies that have been recently reviewed [113].  3 
E. coli CNF1 activates proteins belonging to the Rho family of small GTP-binding proteins, which  4 
induce  the  rearrangement  of  the  actin  cytoskeleton  to  cause  a  phagocytic-like  behavior  called  5 
macropinocytosis  [120–122].  Previous  studies  have  demonstrated  that  these  virulence  factors  can  6 
directly induce apoptosis or necrosis, depending on concentration, in a variety of cell types [123,124].  7 
UPEC CNF1 activates the Cdc42 and Rac proteins to induce apoptosis in CNF1-intoxicated 5637  8 
bladder epithelial  cells [124].  In  addition to  cell  death,  the role  of CNF in  regulating  cell fate  is  9 
controversial.  Previous  reports  [125,126]  showed  that  the  Rac-activating  toxin  CNF1  causes  10 
aneuploidy and multinucleation and prevents the ultraviolet-B-induced apoptosis in epithelial cells  11 
through the Akt/IkappaB kinase-regulated Bcl-2 pathway. The contribution of cytotoxic CNF1 in the  12 
pathogenesis of E. coli infection needs further investigation.  13 
Heat-labile enterotoxin (LT) is an important diarrheal agent produced by E. coli [127,128]. Similar to  14 
Stxs, LT is an AB toxin, which consists of a B pentamer and a monomeric A subunit. Nontoxic B  15 
pentamer adheres to the oligosaccharide portion of ganglioside GM1 on the surface of eukaryotic cells  16 
and mediates endocytosis of the toxin. The monomeric A subunit possesses ADP-ribosyltransferase  17 
activity  and  activates  adenylate  cyclase  to  elevate  cyclic  AMP  levels.  A  constitutive  increase  of  18 
intracellular cylic AMP leads to an imbalance of electrolytes and results in diarrhea [127–129]. Previous  19 
reports have shown that LT has a variety of adjuvant activities, such as increasing the production of  20 
antibodies, activating B cells and CD4
+ cells, and suppressing the number of CD8
+ cells [130–135]. LT  21 
is further divided into type I (LT-1) and type II (LT-IIa and LT-IIb), depending on its distinct receptor  22 
binding specificity and immunomodulatory abilities [128]. LT-IIa, but not LT-IIb, induces apoptosis in  23 
CD8
+ T cells in vitro [136]. In vivo treatment with LT-1 increases the serum levels of corticosterone to  24 
induce  apoptosis  of  immature  T  and  B  cell  populations  by  a  Fas-  and  TNFR1-independent,   25 
caspase-dependent, and apoptosis-inducing factor-independent mechanism [137,138]. LT-1-induced in  26 
vivo apoptosis requires intact ADP-ribosyltransferase activity and partially protects by overexpression of  27 
Bcl-2 [137]. In vitro studies have shown that the B subunit of LT induced selective loss of CD8
+ T cells  28 
by  triggering  apoptosis  through  c-Myc,  NF-B,  and  caspase-dependent  and  -independent  pathways  29 
[139–142]. The immunomodulatory abilities of the LT B subunit relied on its binding to GM1 because  30 
non-binding mutants did not have pro-apoptotic properties [130–132,139]. The mechanisms by which  31 
LT induces apoptosis in vivo and in vitro and in different subsets of lymphoid cells might be quiet  32 
different [137,138,143].  33 
4.3. Cytotoxicity of V. cholerae  34 
Vibrio cholera, a Gram-negative bacterium, is the causative agent of severe diarrhea cholera, which  35 
leads to dehydration and metabolic acidosis [144,145]. Regardless of the fact that there are at least   36 
200 serogroups of V. cholera, only the O1 and O139 serogroups have been associated with cholera [146].  37 
V.  cholera  secretes  a  variety  of  toxins,  including  cholera  enterotoxin,  zonula  occludens  toxin,  38 
accessory  cholera  enterotoxin,  hemolysin/cytolysin,  Shiga-like  toxin,  heat-stable  enterotoxin,  new  39 
cholera  toxin,  sodium  channel  inhibitor,  and  thermostable  direct  hemolysin,  all  of  which  have  40 Toxins 2010, 2                                       
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deleterious effects on eukaryotic cells [147]. Because of the massive, dehydrating diarrhea caused by  1 
cholera enterotoxin, also called cholera toxin (CT), it plays a pivotal role in cholera diseases [148].   2 
CT is an oligomeric complex composed of one A subunit (CTA) and five B subunits (CTB)[149]. The  3 
A subunit is responsible for the direct toxic activity that is due to its elevation of cAMP in cells by  4 
ADP-ribosylation of Gs protein, a regulator of adenylate cyclase, and the B subunit that serves to  5 
bind the holotoxin to the receptor, the ganglioside GM1 [150–153]. CT and its purified CTB process  6 
the immunosuppressive effect, which owes not only to proliferation inhibition but also to apoptosis  7 
induction  in  lymphoid  cells.  Previous  studies  have  shown  that  no  matter  whether  CT  or  CTB  8 
preferentially  induced  apoptosis  in  CD8+  T  cell  population,  the  mechanism  is  still  unclear   9 
[136,154–156]. Besides, CT also stimulates apoptosis in human lung cancer cell lines and the murine  10 
myelomonocytic  leukemia  cell  line,  WEHI-3B,  but  down-regulation  of  Bcl-2  and  inhibition  of  11 
apoptosis  developed  in  a  CT  resistant  clone  [157,158].  However,  the  mechanism  of  CT-induced  12 
apoptosis remains largely unknown and requires further investigation.  13 
5. Concluding Remarks  14 
The effects of cytopathic enterotoxins are pro-apoptotic as well as necrotic-like, depending on the  15 
types  of  cells  and  the  dosages  of  stimulation.  In  general,  there  are  two  or  more  phenomena  under  16 
cytolysin stimulation. Apoptotic signaling caused by enterotoxins is diverse because several intracellular  17 
organelles are generally involved. Upon the formation of pores following PFT stimulation, supporting  18 
the  membrane  integrity  is  important  for  cell  survival.  Statins,  the  cholesterol-lowering  agents,  have  19 
recently  been  used  to  inhibit  pneumococcal  cholesterol-dependent  cytolysin  pneumolysin-induced  20 
cytotoxicity  on  endothelia  and  epithelia  [159].  Inhibiting  cell  death  via  the  stimulation  of  virulent  21 
enterotoxins is a key strategy for treating patients with infectious diseases [17,85].  22 
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